# Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

> **NCT06982547** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **PersonGen BioTherapeutics (Suzhou) Co., Ltd.** · enrollment: 24 (estimated)

## Conditions studied

- Rheumatoid Arthritis (RA)

## Interventions

- **BIOLOGICAL:** UTAA91 injection

## Key facts

- **NCT ID:** NCT06982547
- **Lead sponsor:** PersonGen BioTherapeutics (Suzhou) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06
- **Primary completion:** 2027-12
- **Final completion:** 2040-06
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06982547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06982547, "Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06982547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*